FindTrial
Sign In

comparison of Clonidine and Dexmedetomidine for the duration of Post-operative Pain relief by Femoro-Sciatic Nerve Block in the patients of below knee Surgeries.

A comparative study of clonidine and dexmedetomidine as an adjuvant to levobupivacaine in ultrasound guided femoro-sciatic block for postoperative analgesia in below knee surgeries under subarachnoid block (a randomized controlled trial)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/10/006328
Enrollment
90
Registered
2015-10-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: A comparative study of clonidine and dexmedetomidine as an adjuvant to levobupivacaine in ultrasound guided femoro-sciatic block for postoperative analgesia in below knee surgeries unde

Sponsors

Dr RPGMC Kangra at Tanda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria â?? 1. Males and females between the age group 20-60 years. 2. ASA class I-II. 3. BMI 18.5-39.9. 4. Undergoing surgeries of leg and foot.

Exclusion criteria

Exclusion criteria: 1. Patientâ??s refusal for block. 2. History of cardiac, renal or hepatic disease, CNS disorders, neuropathy. 3. Chronic treatment with calcium channel blockers. 4. Patients having bleeding disorders. 5. Hypersensitivity to local anaesthetics. 6. Local infection at the site where needle for block is to be inserted. 7. Knee surgery. 8. Allergic to study drugs. 9. Patients with known bradyarrythmia and on beta blocker therapy.

Design outcomes

Primary

MeasureTime frame
The primary outcome measure in this study is the time to first analgesic request.Timepoint: The primary outcome measure in this study is the time to first analgesic request.—

Secondary

MeasureTime frame
The secondary outcome measures include the number of supplemental analgesic requirements, VAS pain, nausea, patient satisfactionTimepoint: The secondary outcome measures include the number of supplemental analgesic requirements, VAS pain, nausea, patient satisfaction—

Countries

India

Contacts

Public ContactDr Shelly Rana

Dr. RPGMC Kangra at Tanda

bhanurpgmc@gmail.com9418016807

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026